A link between nuclear RNA surveillance, the human exosome and RNA polymerase II transcriptional termination by de Almeida, Sérgio F. et al.
A link between nuclear RNA surveillance, the
human exosome and RNA polymerase II
transcriptional termination
Se ´rgio F. de Almeida, Ana Garcı ´a-Sacrista ´n, Noe ´lia Custo ´dio and
Maria Carmo-Fonseca*
Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal
Received November 23, 2009; Revised June 14, 2010; Accepted July 25, 2010
ABSTRACT
In eukaryotes, the production of mature messenger
RNA that exits the nucleus to be translated into
protein in the cytoplasm requires precise and exten-
sive modification of the nascent transcript. Any
failure that compromises the integrity of an mRNA
may cause its retention in the nucleus and trigger
its degradation. Multiple studies indicate that
mRNAs with processing defects accumulate in
nuclear foci or ‘dots’ located near the site of tran-
scription, but how exactly are defective RNAs
recognized and tethered is still unknown. Here, we
present evidence suggesting that unprocessed
b-globin transcripts render RNA polymerase II
(Pol II) incompetent for termination and that this
quality control process requires the integrity of the
nuclear exosome. Our results show that unpro-
cessed pre-mRNAs remain tethered to the DNA
template in association with Pol II, in an Rrp6-
dependent manner. This reveals an unprecedented
link between nuclear RNA surveillance, the exosome
and Pol II transcriptional termination.
INTRODUCTION
In eukaryotes, the production of mature messenger RNA
that exits the nucleus to be translated into protein in the
cytoplasm requires precise and extensive modiﬁcation of
the nascent transcript (1). The initial primary transcripts
synthesized by RNA polymerase II (pre-mRNAs) undergo
several processing steps that include addition of a
7-methylguanosine cap at the 50-end, splicing of introns,
and 30-end formation by cleavage and polyadenylation.
During processing, pre-mRNA assembles together with
RNA binding proteins into ribonucleoprotein particles
[mRNPs; (2,3)]. Mature particles are exported to the cyto-
plasm and several lines of evidence indicate that mRNPs
move from the sites of transcription to the nuclear pores
by random Brownian motion (4–10). As diffusion cannot
be regulated, trafﬁc control of newly synthesized mRNA
molecules is thought to rely on retention at dedicated sites
within the nucleus (11). A failure that compromises the
integrity of an mRNA may cause its retention in the
nucleus and trigger its degradation. Such a surveillance
mechanism operates in close proximity to the gene
template and, at least in yeast, at the nuclear pore (12).
Multiple studies indicate that mRNAs with processing
defects accumulate in nuclear foci or ‘dots’ located near
the site of transcription, in mammalian cells (13) as well as
yeast (14–17). In Saccharomyces cerevisiae, the nuclear
exosome contributes to post-transcriptional tethering of
faulty mRNAs within dots that are adjacent to the tran-
scription site (15,18–20), but how exactly are defective
RNAs recognized and tethered is still unknown.
The exosome is a multiprotein complex with
ribonucleolytic activity that has a large number of sub-
strates and participates in a wide range of cellular func-
tions. In the cytoplasm, the exosome catalyzes mRNA
turnover, nonsense-mediated mRNA decay and nonstop
decay, whereas in the nucleus, the exosome is involved in
the maturation of rRNA, snoRNA and snRNA, and in
the degradation of incorrectly processed RNA precursors
(21,22). More recent studies reveal additional roles of the
exosome in gene silencing and in regulating the expression
of non-coding RNAs (23). The human exosome consists
of a nine-subunit core devoid of ribonuclease catalytic
activity, and two associated hydrolytic RNases, Rrp44
(Dis3) and Rrp6 (PM/Scl-100). Although the structure
and function of the exosome is widely conserved, Rrp44
copuriﬁes with the rest of the core in S. cerevisiae and in
Drosophila melanogaster, but not in Homo sapiens or
Trypanosoma brucei (24). Furthermore, Rrp6 associates
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human cells it is present both in the nucleus and in the
cytoplasm (26). It remains unclear whether these differ-
ences reﬂect distinct functional properties of the
exosome across species.
Here, we investigated in more detail and at higher reso-
lution the relation between the exosome and unprocessed
b-globin transcripts retained near the site of transcription
in human cells. Our results show that deﬁciently processed
pre-mRNAs remain tethered to the DNA template in as-
sociation with RNA polymerase II (Pol II), in an
Rrp6-dependent manner.
MATERIALS AND METHODS
Cell culture and transfections
The Flp-In
TM T-REx
TM-293 cell line was purchased
from Invitrogen Life Technologies, and grown as mono-
layer in Dulbecco’s modiﬁed Eagle medium (DMEM)
supplemented with 10% fetal bovine serum and 2mM
L-glutamin (all cell culture reagents were from Gibco).
Isogenic, inducible stable cell lines were generated
through Flp recombinase-mediated integration by
cotransfecting the Flp-In
TM T-REx
TM-293 host cell line
harboring a single Flp recombination target site with a
plasmid expressing the Flp recombinase (pOG44,
Invitrogen) and pcDNA5/FRT/TO-bWT or pcDNA5/
FRT/TO-bIVS1 constructs at a 9:1 ratio using
FuGENE 6 Transfection Reagent (Roche). Expression
of bWT or bIVS1 was induced with 1mg/ml tetracycline.
The murine erythroleukemia (MEL) cell lines were previ-
ously described (13).
Gene constructs
pcDNA5/FRT/TO-bWT and pcDNA5/FRT/TO-bIVS1
were constructed by inserting a NcoI–Acc65I (blunted)
fragment containing the human b-globin (HBB) gene
(from ATG to  1800bp past the poly(A) site) into the
KpnI (blunted) site of pcDNA5/FRT/TO (Invitrogen).
The wild-type (bWT) and mutant (bIVS1) HBB genes
were described previously (27,28).
RNA interference
To reduce the levels of exosome proteins by RNA inter-
ference (RNAi), we used siRNA duplexes and
shRNA-expressing lentiviruses. For experiments using
siRNA oligomers, both single and double transfections
were performed. As unspeciﬁc siRNA control a sequence
targeting the ﬁreﬂy luciferase gene (GL2) was used (29).
Cells were plated 1day before transfection such that they
were 30–50% conﬂuent at the time of transfection. The
siRNA duplexes were transfected using Lipofectamine
2000 transfection reagent (Invitrogen) according to the
manufacturer’s protocol. Cells were either harvested
1day after transfection, or re-transfected with the
same siRNA duplex and harvested 2 days later. RNAi
experiments using shRNA-expressing lentiviruses were
performed as described (30) with the following modiﬁca-
tions: cells were seeded at a density of 1.8 10
5 cells per
well in a 24-well plate, infected with 20mlo f
unconcentrated shRNA lentivirus supernatant from the
96-well plate viral production, incubated for 48h before
addition of 5mg/ml puromycin for selection and harvested
after 3–4 days of selection. The siRNA and shRNA se-
quences are listed in Supplementary Table S1.
RNA isolation and fractionation
Total cellular RNA was extracted using TRIzol
(Invitrogen). Nuclear and cytoplasmic RNA fractions
were isolated as described (31). Nuclear RNA was
further fractionated into chromatin-associated and
nucleoplasmic fractions as described (32–35).
RT–PCR
cDNA was made using Superscript II Reverse
Transcriptase (Invitrogen) according to the manufactur-
er’s instructions. PCR products were separated by gel elec-
trophoresis, detected by ethidium bromide, scanned with
Typhoon (GE Healthcare) and analyzed with the
ImageQuant software (Molecular Dynamics, Sunnyvale,
CA, USA). Real-time quantitative PCR analysis was per-
formed in the 7500 Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA), using SYBR Green
PCR master mix (Applied Biosystems), as previously
described (36). Gene-speciﬁc primer pairs are presented
in Supplementary Table S2.
In situ hybridization and immunoﬂuorescence analysis
Cells were ﬁxed in 3.7% paraformaldehyde in PBS
for 10min and permeabilized with 0.5% Triton
X-100/2mM VRC in PBS. Fluorescence in situ hybridiza-
tion (FISH) was carried out as described (13). The probe
used for FISH was complementary to the 50-region of the
HBB gene up to the BamHI site in exon II. The probe was
labelled either by nick-translation with digoxigenin-
11-dUTP (Roche) or by in vitro transcription with
digoxigenin-11-UTP (Roche). Digoxigenin was detected
using a Cy3-conjugated mouse anti-digoxin antibody
(1:200, Jackson ImmunoResearch Labs, Inc.).
Simultaneous detection of RNA and protein was as pre-
viously described (37) with the exception that immuno-
ﬂuorescence preceded FISH. Images were acquired on
Zeiss LSM 510 META confocal microscope using the
PlanApochromat 63 /1.4 objective. AlexaFluor488 ﬂuor-
escence was detected using the 488nm line of the argon
ion laser. Cy3 was excited with the DPSS 561-10 laser.
Line proﬁles were obtained from unprocessed images
using the LSM 510 software.
Western blotting
Whole-cell lysates were prepared, resolved and transferred
as described (38). Incubations with primary antibodies
were followed by incubations with the appropriate second-
ary antibodies (BioRad) and by detection using enhanced
luminescence (Amersham).
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ChIP was performed according to Listerman et al. (39)
with some modiﬁcations. Cell extracts were sonicated
with a Sanyo Soniprep 150 at an amplitude of 10
microns with six 20s bursts, resulting in 200–400bp chro-
matin fragments. The DNA fragments crosslinked to
proteins were enriched by immunoprecipitation with
rabbit polyclonal antibodies (anti-RNA Pol II, N20;
anti-CBP80; anti-EXOSC10) and protein A sepharose
beads (Sigma). Control (mock) immunoprecipitations
were performed with anti-HA antibody. DNA from
immunoprecipitated and input samples was extracted
with UltraPure Phenol:Chloroform:Isoamyl Alcohol
25:24:1 (Invitrogen) and analyzed by quantitative
real-time PCR, with the input consisting of a chromatin
amount equivalent to that used for immunoprecipitation.
The total number of cells was kept constant between ex-
perimental batches in order to yield similar amount of
input chromatin and therefore avoid variability due to
changes in precipitation efﬁciency (40). Primers used for
PCR are listed in Supplementary Table S2. The relative
occupancy of the immunoprecipitated protein at each
DNA site was estimated as follows: 2^(Ctmock –
Ctspeciﬁc), where Ctmock and Ctspeciﬁc are mean threshold
cycles of PCR done in triplicate on DNA samples from
mock and speciﬁc immunoprecipitations (41).
Antibodies
The following primary antibodies were used: rabbit poly-
clonal antibodies anti-RNA Pol II, N20 (Santa Cruz
Biotechnology); anti-CBP80 (kindly provided by Dr
Elisa Izaurralde, Max Planck Institute for
Developmental Biology, Tu ¨ bingen, Germany); anti-PM/
Scl-100, anti-hRrp40, anti-hRrp41, anti-hRrp46 (kindly
provided by Dr Ger Pruijn, University of Nijmegen, The
Netherlands); anti-EXOSC10 (ab50558; Abcam); anti-HA
(Y-11; from Santa Cruz Biotechnology); and mouse
monoclonal anti b-actin (Sigma).
RESULTS
Human exosome subunit Rrp6 is required for retention of
unprocessed b-globin RNA at the transcription site
To investigate the molecular mechanisms involved in
quality control of deﬁciently processed pre-mRNA, we
used the well characterized human b-globin (HBB) gene
as a model system. We engineered 293 human embryonic
kidney cell lines to stably express a single
tetracycline-inducible b-globin transgene integrated in
the genome through site-speciﬁc DNA recombination.
The b-globin transgene was either wild-type (bWT) or a
mutant variant (bIVS1) that lacks completely the second
intron (Figure 1A). We have previously shown that the
bIVS1 mutation abolishes splicing of the ﬁrst intron,
reduces efﬁciency of 30-end cleavage and causes retention
of the RNA at the transcription site (13,37). Here, we were
interested in determining whether the exosome subunit
Rrp6 is involved in preventing release of these aberrantly
processed transcripts from the site of transcription. We
ﬁrst examined the distribution of bWT and bIVS1 RNA
by FISH. Tetracycline induces expression of the transgene
and nascent transcripts are detected as a focus in the
nucleus (Figure 1B), as previously described in stably
transfected MEL cells (13,37). The wild-type mRNA is
exported from the nucleus and progressively accumulates
in the cytoplasm (Figure 1B). In contrast, the mutant
RNA is not detectable by FISH in the cytoplasm
(Figure 1B). Within 2h after removal of tetracycline,
nuclear foci of wild-type b-globin RNA are no longer
detected in most cells, consistent with transcriptional
shutdown of the transgene. We have previously shown
that treating MEL cells with the transcription inhibitor
actinomycin D for a short period of time (5–15min)
causes a dramatic, rapid reduction in the relative
number of cells that contain a detectable focus of bWT
transcripts within the nucleus, whereas the percentage of
cells harboring bIVS1 RNA foci remained largely un-
altered, suggesting that these mutant RNAs were not
being released from the site of transcription (13). Here,
we observe a similar result by speciﬁcally inhibiting tran-
scription of the transgene by removal of tetracycline
(Figure 1C).
To study the role of Rrp6, we reduced the levels of the
protein by RNA interference (RNAi). To ﬁnd the most
effective conditions, a number of small interfering RNA
(siRNA) duplexes were synthesized, and both single and
double transfections were performed. Two different syn-
thetic siRNAs resulted in similar phenotypes to those
described below. As unspeciﬁc siRNA control a
sequence targeting the ﬁreﬂy luciferase gene (GL2) was
used (29). Western blot analysis shows that after 3 days
of siRNA treatment, Rrp6 levels are reduced to 20%
(Figure 1D). The relative number of cells that contain a
detectable nuclear focus of bWT transcripts is similar in
control and Rrp6 knockdown cells, following both tetra-
cycline induction and tetracycline removal. In marked
contrast, the percentage of cells with bIVS1 RNA foci is
drastically reduced in the absence of Rrp6 (Figure 1E).
Next, we used a biochemical approach to obtain quan-
titative information on nascent b-globin transcripts that
are associated with chromatin and transcripts that have
been released into the nucleoplasm. Brieﬂy, cells are lysed
and nuclei separated from the cytoplasmic fraction. After
treatment of nuclei with urea and a mild detergent, cen-
trifugation pellets RNAs associated with Pol II and chro-
matin, whereas RNAs found in the supernatant are
considered to have been released from the DNA
template into the nucleoplasmic fraction (32–35). In agree-
ment with previous studies (35), immunoblot analysis
revealed that tubulin was exclusively detected in the cyto-
plasmic fraction, histone H3 was only detected in the chro-
matin fraction, RNA Pol II was predominantly detected in
the chromatin fraction and the spliceosomal protein
U2AF65 was detected in both nucleoplasmic and chroma-
tin fractions (Supplementary Figure S1). Equal amounts
of RNA were taken from cytoplasmic, chromatin-
associated and nucleoplasmic fractions, then reverse
transcribed with random primers and PCR ampliﬁed
using primer pairs that detect total, spliced and unspliced
b-globin RNA, as indicated in Figure 2. The abundance of
Nucleic Acids Research, 2010,Vol.38, No. 22 8017Figure 1. Human exosome subunit Rrp6 is required for retention of mutant b-globin RNA at the transcription site. (A) Schematic representation of
wild-type (bWT) and mutant (bIVS1) human b-globin constructs. Exons are numerated (I, II and III). (B) RNA transcribed from bWT and bIVS1
transgenes was visualized by FISH, before (–) and after (+) tetracycline induction. Cells were double-labeled for b-globin RNA (red staining) and
total DNA (blue staining). After tetracycline induction, nascent transcripts are detected as a focus in the nucleus. The wild-type mRNA is exported
from the nucleus and accumulates in the cytoplasm, whereas the mutant RNA is not detectable in the cytoplasm. (C) The proportion of cells with a
nuclear RNA focus was estimated in three independent experiments. Cells were treated with tetracycline for 8h (transcription on). Tetracycline was
then removed and cells analyzed 2h later (transcription off). The mean proportion of cells with a nuclear RNA focus is plotted (error bars represent
standard deviation). For each experimental condition, 10 microscopic ﬁelds were counted, with a total of 500–700 cells. After transcriptional shutoff,
very few cells contain a focus of wild-type transcripts; in contrast, foci of mutant transcripts are still visible in a large proportion of cells. (D) Western
blot analysis of Rrp6 and b-actin proteins in whole lysates from cells treated with siRNA against Rrp6 or negative control (GL2). The ﬁrst two lanes
contain equivalent amount of total cell protein, as shown by similar levels of b-actin. The subsequent lanes contain progressive 2-fold dilutions of
protein from control cells to allow estimation of degree of knockdown. (E) Proportion of cells with a nuclear RNA focus in control and
Rrp6-depleted cells. Cells were treated with siRNAs against Rrp6 and control siRNA (GL2). After tetracycline induction for 8h (transcription
on), tetracycline was removed and cells analyzed 2h later (transcription off). The histogram depicts mean and standard deviation for three inde-
pendent experiments. Total of 500–700 cells counted for each experimental condition. In the absence of Rrp6, there is a drastic reduction in the
relative number of cells with a focus of mutant transcripts.
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GAPDH RNA detected in the same fraction. Total and
spliced bWT RNA is detected in cytoplasmic,
nucleoplasmic and chromatin-associated fractions
(Figure 2A and B), consistent with our in situ results
indicating that these transcripts are efﬁciently exported
to the cytoplasm (Figure 1B). In contrast, the bIVS1 con-
struct failed to express signiﬁcant amounts of RNA, as
previously reported (27). Moreover, we do not detect
spliced bIVS1 RNA in any of the fractions (Figure 2B),
consistent with our previous observation that these tran-
scripts fail to be spliced (37). As expected, no signiﬁcant
amount of unspliced RNA is present in the cytoplasm
(Figure 2C). In the nucleus, unspliced RNA appears
enriched in the chromatin-associated fraction, consistent
with the view that most wild-type b-globin introns are
removed co-transcriptionally (13). Similar results are
obtained for bWT transcripts in GL2 and Rrp6
knockdown cells, indicating that Rrp6 is not required
for splicing and export of these RNAs. In control cells,
unspliced mutant RNA is also predominantly found in the
chromatin fraction (Figure 2C). However, in Rrp6
knockdown cells bIVS1 transcripts become equally
abundant in chromatin-associated and nucleoplasmic
fractions (Figure 2A and C). These results strongly
suggest that Rrp6 is required for retention of unspliced
mutant RNA in association with chromatin, but loss of
Rrp6 is not sufﬁcient to trigger export of unspliced RNA
to the cytoplasm.
Deﬁciently processed b-globin RNA is stalled in
association with Pol II on the gene template
Studies in S. cerevisiae suggest that errors in the mRNP
biogenesis pathway lead to post-transcriptional retention
of RNAs within ‘dots’ that are adjacent to but distinct
from their transcription site (18,19). However, in mouse
cells we detect defectively processed b-globin RNAs
accumulated in discrete foci that are indistinguishable
from the transcription sites (13). To investigate whether
retention of unprocessed b-globin RNA occurs co-
transcriptionally, we carried out chromatin immunopre-
cipitation (ChIP) with antibodies speciﬁc for the CBP80
subunit of the cap-binding complex (CBC). Because CBC
binds the 50-end of Pol II transcripts and newly
synthesized RNAs lie adjacent to the gene template,
formaldehyde-induced cross-links are able to capture
nascent RNA–protein complexes (39). Cellular DNA
was sonicated to 200- to 400-bp fragments, and
immunoprecipitated fragments were analyzed by quanti-
tative real-time PCR using primer pairs across the
promoter (1), the open reading frame (2,3) and within
the 30-ﬂanking region (4,5) of the b-globin gene
(Figure 3A). In order to measure the relative occupancy
of a protein of interest at distinct target genomic se-
quences, quantitative PCR data can be expressed as
percent precipitated DNA relative to input. However,
using this method alone a differential enrichment of core
histones at speciﬁc genomic sites was observed in control
experiments lacking antibody or using antibodies directed
against non-histone proteins (42). This unexpected effect
may be caused by the fact that different relative levels of
DNA from distinct genomic loci are recovered during
the extraction procedure (43). Thus, it is important to
normalize ChIP data relative to control immunopreci-
pitations (41,42). Distributions of ChIP signals expressed
as percent precipitated DNA relative to input with
anti-CBP80 and control antibodies are depicted in
Figure 3B. These results show a signiﬁcantly higher
ChIP signal for CBP80 compared to control antibody.
Furthermore, there is no differential enrichment of ChIP
signals along the b-globin gene in control immunopreci-
pitations. Distributions of CBP80 relative occupancy fol-
lowing normalization to control immunoprecipitations are
depicted in Figure 3C. When compared to uninduced cells,
a 2-fold increase in CBP80 occupancy is detected across
Figure 2. Rrp6 is required for retention of unspliced RNA in associ-
ation with chromatin. RNA transcribed from bWT and bIVS1 trans-
genes was isolated from cytoplasmic (Cyt), nucleoplasmic (Nuc) and
chromatin-associated (Chr) fractions of control (GL2 siRNA) and
Rrp6 depleted cells (Rrp6 siRNA). The RNA was reverse transcribed
with random primers and PCR ampliﬁed using primer pairs that detect
total (A), spliced (B) and unspliced (C) b-globin RNA as illustrated in
the diagrams. The amount of PCR product in each fraction was
estimated by quantitative real-time PCR and normalized to the level
of GAPDH RNA detected in the same fraction. The histograms depict
mean and standard deviation for three independent experiments.
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(Figure 3C), consistent with previously reported data for
other mammalian genes (39). However, we note that while
in the wild-type gene (bWT) all primers show signals of
similar intensity, in the mutant gene (bIVS1) the primers
positioned towards the 30-end give much higher signal
(Figure 3C). We also performed ChIP with polyclonal
antibodies that recognize the N-terminal region of the
large subunit of Pol II (N20). These antibodies bind Pol
II in a phosphorylation-independent manner, i.e. they rec-
ognize Pol II with either the hyperphosphorylated or the
hypophosphorylated CTD. Before transcriptional
activation, we detect a signiﬁcant amount of Pol II
loaded in the promoter-proximal region (Figure 3C), as
previously reported for other mammalian genes (39,44).
Upon transcriptional induction with tetracycline, a signiﬁ-
cantly increased signal of Pol II is detected in downstream
regions of both bWT and bIVS1 genes (Figure 3C). Along
the bWT gene, Pol II signal remained high past the
poly(A) site, but then decreased after the CoTC
sequence consistent with the view that this element is es-
sential for transcriptional termination of the human
b-globin gene (45,46). A signiﬁcantly higher Pol II occu-
pancy towards the 30-end is observed in bIVS1 compared
Figure 3. Rrp6-dependent stalling of mutant b-globin RNA on the gene template in association with Pol II. (A) Schematic diagram indicating the
gene regions ampliﬁed by primer sets. The black box represents the CoTC sequence. (B) Aliquots of sheared chromatin from the same number of
cells were used for ChIP with anti-CBP80 and control (anti-HA) antibodies (-IP). Data are expressed as percent precipitation relative to input
chromatin [calculated as (amount of ChIP DNA)/ (amount of input DNA)  100]. (C) ChIP was performed in cells expressing bWT and bIVS1
transgenes, using anti-CBP80 and anti-Pol II antibodies. Transcription was induced with tetracycline. Results are expressed as ‘relative occupancy’,
calculated as enrichment from speciﬁc immunoprecipitations normalized to enrichment from control immunoprecipitations. (D and E) Relative
occupancy of CBP80 and Pol II in control and Rrp6-depleted cells after induction with tetracycline. All histograms depict mean and standard
deviation for at least three independent experiments. The asterisks denote statistically signiﬁcant differences: *P<0.05; **P<0.01.
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sequence (Figure 3C). Taking into consideration that the
ChIP analysis provides information about CBP80 and Pol
II density across the two genes, and assuming that the
association of capped nascent RNA with chromatin is
mediated by the association of transcribing Pol II with
DNA, these data suggest that polymerase release down-
stream of the CoTC is inefﬁcient in the bIVS1 mutant
gene.
Rrp6 regulates termination of unprocessed RNA
Because studies in S. cerevisiae indicate that Rrp6 regu-
lates post-transcriptional RNA tethering (20), we asked
whether Rrp6 plays any role in co-transcriptional RNA
retention. In the wild-type gene, knockdown of Rrp6 has
no apparent effects on the distribution of CBP80 and Pol
II (Figure 3D and E). However, we observe signiﬁcantly
reduced occupancy with antibodies against CBP80
(Figure 3D) and Pol II (Figure 3E) at the 30-end of the
bIVS1 gene in Rrp6-depleted cells compared to the
negative control knockdown. A similar result is observed
when we examine the distribution of CBP80 and Pol II
expressed as percent precipitated DNA relative to input
(Supplementary Figure S2). Taken together with the
results depicted in Figure 2C, these data indicate that in
the absence of Rrp6 both Pol II and unspliced bIVS1
transcripts are released from the DNA template. As
bIVS1 transcripts were previously found to be deﬁciently
cleaved at the 30-end (37), we asked whether
down-regulation of Rrp6 causes release of uncleaved
RNA. We used a primer downstream from the cleavage
site to examine the amount of b-globin RNA that is
uncleaved at the poly(A) site in the cytoplasmic,
nucleoplasmic and chromatin fractions (Figure 4).
As expected, both bWT and bIVS1 RNAs that are
uncleaved at the poly(A) site are enriched in the chromatin
fraction. However, following Rrp6 knockdown the levels
of uncleaved bIVS1 RNAs become essentially the same in
chromatin and nucleoplasmic fractions (Figure 4).
Therefore, we conclude that Rrp6 knockdown promotes
release of uncleaved b-globin transcripts from the chroma-
tin template.
Unprocessed transcripts are slowly degraded in the nucleus
Because the exosome participates in selective elimination
of RNA molecules that are not properly processed (47),
we asked whether the turnover of unprocessed mutant
RNA is faster compared to wild-type RNA. Tetracycline
was added to the culture medium to induce transcription
of the transgenes, and removed after 3.5h. The levels of
unspliced and spliced RNA were measured at 1, 2 and 4h
after tetracycline removal. As shown in Figure 5A, tetra-
cycline induction results in accumulation of similar levels
of unspliced RNA from wild-type and mutant b-globin
transgenes. The levels of unspliced RNAs persist for
 1h after transcriptional shutoff, and decrease progres-
sively thereafter. At 4h after transcriptional shutoff, the
levels of unspliced transcripts is similar to that detected in
uninduced cells. In parallel, tetracycline induces a signiﬁ-
cant increase of spliced bWT mRNA, while the levels of
bIVS1 mRNA do not change relative to uninduced cells
(Figure 5B). These results show that unspliced bIVS1
RNA takes longer than bWT RNA to return to uninduced
levels, suggesting that the kinetics of degradation of un-
processed pre-mRNA is slower than the normal process-
ing of pre-mRNA into mRNA. Degradation of the
unprocessed RNA is slower, perhaps because it requires
dissociation of the stalled transcript from Pol II in order
to provide entry sites for exonucleases. Indeed, while
unspliced and uncleaved pre-mRNAs are stalled in asso-
ciation with Pol II, they provide no entry sites for exo-
nucleases. The mutant transcripts that are not cleaved at
the poly(A) site do not have a poly(A) tail covered by
poly(A)-binding proteins. Therefore, once they dissociate
from Pol II these transcripts will expose unprotected
30-ends and will be most probably rapidly degraded.
Thus, the data suggest that defects in pre-mRNA process-
ing delay but do not irreversibly block Pol II transcription
termination. In conclusion, the results show that unpro-
cessed b-globin RNA is recognized by the exosome and
retained at the transcription site. However, the subsequent
degradation of unprocessed transcripts is a relatively slow
process that takes longer than the normal turnover of
wild-type RNA.
Rrp6 and core exosome subunits are recruited to b-globin
transcription sites
A direct role of the exosome in co-transcriptional RNA
surveillance is supported by studies in Drosophila showing
that exosome subunits are recruited to transcriptionally
active genes (48). To examine recruitment of the
exosome to b-globin transcription sites, we combined
FISH with immunoﬂuorescence using antibodies against
Rrp6 and the core subunits (Figure 6A and B). We detect
Figure 4. Rrp6 is required for retention of uncleaved RNA in associ-
ation with chromatin. RNA transcribed from bWT and bIVS1 trans-
genes was isolated from cytoplasmic (Cyt), nucleoplasmic (Nuc) and
chromatin-associated (Chr) fractions of control (GL2 siRNA) and
Rrp6 depleted cells (Rrp6 siRNA). The RNA was reverse transcribed
with random primers and PCR ampliﬁed using a pair of primers that
detects uncleaved b-globin RNA, as illustrated in the diagram
(the black box represents the CoTC sequence). The amount of PCR
product in each fraction was estimated by quantitative real-time PCR
and normalized to the level of GAPDH RNA detected in the same
fraction. The histogram depicts mean and standard deviation for
three independent experiments.
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high concentration at the site of b-globin transgene tran-
scription. Similar results are observed in cells that express
the wild-type or mutant transgene. Because recent reports
suggest that Rrp6 can act independently of the exosome
core (49,50), we performed RNAi of Rrp6 and the core
component Rrp46. As shown by western blot analysis,
knockdown of Rrp6 results in depletion of this exosome
subunit only, with no effect on the amount of Rrp46 in the
cell (Figure 6C). In contrast, knockdown of Rrp46 also
reduces the levels of Rrp6 (Figure 6C). A reduction of
Rrp6 upon knockdown of the core components Rrp40
and Rrp41 was also recently reported (51). The stability
of a component of multiprotein complexes often depends
on the presence of the other components, so that when one
protein is depleted, the others become unstable and show
reduced cellular levels. We therefore infer that the
majority of Rrp6 in the cell is in a complex with the
core exosome.
We next examined the association of Rrp6 and b-globin
transgenes at higher resolution using ChIP. As observed
previously in Drosophila heat-shock genes (48), we detect
Rrp6 distributed along the wild-type and mutant b-globin
transgenes (Figure 6D). However, quantitative analysis
shows a higher recruitment of Rrp6 to the promoter
compared to the body of bWT and bIVS1 genes. Most
important, similar levels of Rrp6 are recruited to the
30-end of both bWT and bIVS1 genes, in marked
contrast to the increased density of Pol II and CBP80
observed on the mutant gene. Thus, although Rrp6 most
likely associates with the Pol II elongating complex, the
protein does not seem to remain stably bound to stalled
Pol II molecules on the mutant gene. Yet, in the absence of
Rrp6 both Pol II and unprocessed transcripts are released
from the DNA template (Figure 3C and D). Possibly,
Rrp6 participates in the exchange of factors that associate
with the elongation complex as transcription proceeds
through the poly(A) site and that contribute to render
Pol II termination competent.
DISCUSSION
Since our original observation that incorrectly processed
b-globin mRNA precursors persist accumulated in close
proximity to the gene template after inhibition of tran-
scriptional activity (13), it has been unclear how are
these RNAs tethered into discrete foci or dots within the
nucleus. We now present evidence suggesting that unpro-
cessed b-globin transcripts render Pol II incompetent for
termination and that this quality control process requires
the integrity of the nuclear exosome. Using ChIP experi-
ments to measure the density of polymerases and nascent
transcripts throughout the b-globin gene, we detect ter-
mination defects in a variant form of the gene harboring
a deletion mutation that reduces the efﬁciency of
pre-mRNA splicing and 30-end cleavage. We also show
that unprocessed pre-mRNAs remain tethered to the
gene in association with Pol II by a mechanism that
involves Rrp6.
Transcriptional termination of Pol II is the ultimate step
in the transcription cycle, during which the polymerase
dissociates from the DNA template and releases the
RNA transcript. In mammals, termination by Pol II can
occur from a few base pairs to several kilobases down-
stream from the cleavage and poly(A) site. Two alterna-
tive models have been proposed >20 years ago to explain
this process, but the current view is that most likely both
models contribute to the termination mechanism (52).
According to the allosteric or anti-terminator model, tran-
scription through the poly(A) site leads to conformational
changes of the elongation complex whereas the torpedo
model postulates that cleavage creates an entry site for an
exonuclease at the uncapped 50-monophosphate that will
degrade the RNA and somehow induce dissociation of Pol
II. Termination is intimately coupled to formation of the
30-end of a mature mRNA, which occurs in a two-step
reaction involving endonucleolytic cleavage at the
poly(A) site and subsequent addition of adenine residues
to form a poly(A) tail. The 30-end processing machinery
results from assembly of two multimeric complexes, the
cleavage and polyadenylation speciﬁcity factor (CPSF)
Figure 5. Turnover rates of wild-type and mutant transcripts.
Time-course analysis of bWT and bIVS1 RNA by qRT–PCR. The
upper diagrams show the primers used to distinguish unspliced (A)
and spliced (B) transcripts. Tetracycline was added to the culture
medium to induce transcription for 3.5h and then removed, as
indicated. Error bars show standard deviation from three independent
experiments.
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nizes a conserved hexanucleotide termed the polyaden-
ylation signal located 10–30nt upstream of the poly(A)
site, and CstF binds a less conserved U- or GU-rich
region located up 30nt downstream of the poly(A) site
(52,53).
Mechanistically, transcriptional termination of the
human b-globin gene has been extensively characterized
and can be summarized in the following sequence of
events (54). Pol II transcribes the b-globin gene past the
poly(A) site until it synthesizes the terminator sequence,
which is cleaved by an activity termed co-transcriptional
cleavage or CoTC (45,46,55). This results in exposure of
an unprotected RNA 50-end, the degradation of which by
the Xrn2 exonuclease leads to dissociation of the polymer-
ase from the template as predicted in the torpedo model
(46). Depletion of Xrn2 exonuclease results in a decrease
in termination efﬁciency of both b-globin and b-actin
genes, as shown by an increase in transcripts and Pol II
density beyond the CoTC sequence (46,56). Moreover, it
has been proposed that Pol II termination of the b-globin
gene can occur prior to cleavage at the poly(A) site (54).
Figure 6. Rrp6 and core exosome subunits are recruited to b-globin transcription sites. (A) Cells expressing the wild-type transgene were
double-labeled for b-globin RNA by FISH (red staining) and for protein by indirect immunoﬂuorescence (green staining) using antibodies
speciﬁc for exosome subunits, as indicated. The recruitment of proteins to transcription sites was analyzed drawing a test line across the bWT
transcription site and measuring the relative ﬂuorescence intensity along the line (in arbitrary units) for both the RNA signal and the protein signal.
We considered a positive recruitment when the intensity of the protein signal at the transcription site was >2-fold higher than the global
nucleoplasmic signal. The color of the lines in the graphics corresponds with the color of the detection of RNA and protein in the cell. (B) The
proportion of cells exhibiting recruitment of exosome proteins to bWT transcription sites was quantiﬁed. Values represent average from at least 30
transcription sites analyzed in three independent experiments. Error bars denote standard deviation. (C) Western blot analysis of whole lysates from
cells infected with individual short hairpin RNAs targeting the indicated exosome components. The blot was probed with antibodies against the
indicated exosome subunits and b-actin. (D) Rrp6 relative occupancy in cells expressing bWT and bIVS1 transgenes after tetracycline induction. The
histogram depicts mean and standard deviation for three independent ChIP experiments.
Nucleic Acids Research, 2010,Vol.38, No. 22 8023Here, we validate this model by showing that in
Rrp6-depleted cells uncleaved transcripts are released
from the DNA.
It is important to note that the presence of a CoTC
element has only been identiﬁed in human globin and
mouse serum albumin genes (52,57). For most genes, Pol
II termination is thought to be more tightly coupled with
poly(A) site cleavage. Yet, recent ChIP studies on multiple
human genes reveal extensive co-localization of 30-end
processing factors with Pol II in regions more than a
kilobase downstream of poly(A) sites (44). Most
probably, there are differences in the mechanism of
30-end processing and Pol II termination between genes
and across species (58,59). Therefore, it is likely that
cells have also different mechanisms to control faulty
nascent transcripts. It remains to be established whether
in other mammalian genes the surveillance of deﬁciently
processed RNAs involves termination as described here
for the b-globin gene, or occurs post-transcriptionally as
observed in S. cerevisiae (18–20).
In yeast, defects in mRNA 30-end formation cause ac-
cumulation of aberrant transcripts in foci near the sites of
transcription, but in the absence of Rrp6 aberrant
pre-mRNAs are no longer retained (14,15,60). This led
to the proposal that release of newly synthesized mRNA
from the transcription site may act as an
exosome-dependent checkpoint for mRNA integrity (61).
Here, we show that the involvement of Rrp6 in retention
of aberrant pre-mRNAs near the sites of transcription is
conserved from yeast to mammals. Most important, we
ﬁnd that Rrp6 is required to prevent transcription termin-
ation of an RNA processing mutant gene, which implies a
novel cellular role for this protein in addition to its
well-characterized exoribonuclease activity. Despite
evidence that Rrp6 can act independently of the
exosome core (49,50), we observe co-localization of
Rrp6 and core subunits at b-globin transcription sites.
This observation is consistent with a previous study in
Drosophila showing that the whole exosome complex as-
sociates with elongating Pol II (48). Moreover, we observe
that knocking down a core subunit leads to reduction of
Rrp6, suggesting that the majority of Rrp6 in the cell is in
a complex with the core exosome.
How can the exosome interfere with termination? One
possibility is that the exosome associates with the
elongating polymerase (48) and contributes to trigger ter-
mination upon recruitment of the cleavage and
polyadenylation machinery to the poly(A) signal. It is gen-
erally assumed that the emergence of the poly(A) signal on
the nascent transcript changes the properties of the
elongating complex (probably by dissociation and/or re-
cruitment of speciﬁc factors), rendering the polymerase
competent for termination. In the case of the RNA pro-
cessing defective mutant, failure to assemble a functional
cleavage and polyadenylation complex is somehow sensed
by the exosome and termination becomes less efﬁcient.
A major breakthrough in our understanding of gene
expression was the recent realization that individual
steps from transcription to mRNA translation and decay
are extensively interwoven and integrated (1). Many
aspects of transcription and pre-mRNA processing are
known to be coupled, and in particular, West and
Proudfoot (54) found that termination enhances
pre-mRNA splicing. The data presented in this study
show that defects in splicing and 30-end cleavage reduce
termination efﬁciency, arguing for a bi-directional com-
munication between pre-mRNA processing and transcrip-
tional termination. Although further studies are needed to
establish the molecular links involved in this cooperation,
a recent study in Caenorhabditis elegans identiﬁed an SR
splicing protein, SRp20, as implicated in termination (62).
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